methylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol]

RxCUI
1358612
RxNorm name
methylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol]
Display name
DEPO-Medrol (Injectable)
Full name
methylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol]
Term type
SBD
Status
Active
Strength
40 mg/ml
Dose form
Susp
Route
Injectable
Updated
2026-07-24 06:52:14

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
122012
Active start
122012
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
methylprednisolone acetate40 MG / 1 MLmethylprednisolonemethylprednisolone acetate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Injectable Suspension316950

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
methylprednisolone6902

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRDEPO-Medrol 40 MG/ML Injectable SuspensionNAMES
RxNorm Namemethylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol]NAMES
RxNorm SynonymDepo-Medrol 40 MG/ML Injectable SuspensionNAMES
TTYSBDATTRIBUTES
SPL_SET_ID823b0010-2b57-4e76-b5ac-4a8c2963438fCODES
SPL_SET_ID9f1b7ce6-0733-47fa-8a14-a29a4d026992CODES
SPL_SET_IDaa151d12-bd33-4d26-848f-2195172c9700CODES
RxCUI1358612CODES
MMSL_CODEMTH_RXN_BD2312CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0009-0280-020009-0280Depo-Medrol methylprednisolone acetatePharmacia & Upjohn Company LLCNDA011757
0009-0280-030009-0280Depo-Medrol methylprednisolone acetatePharmacia & Upjohn Company LLCNDA011757
0009-0280-510009-0280Depo-Medrol methylprednisolone acetatePharmacia & Upjohn Company LLCNDA011757
0009-0280-520009-0280Depo-Medrol methylprednisolone acetatePharmacia & Upjohn Company LLCNDA011757
50090-0556-050090-0556DEPO-MEDROL methylprednisolone acetateA-S Medication SolutionsNDA011757

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
NDA0117570009-0280Depo-Medrol methylprednisolone acetateNDAPharmacia & Upjohn Company LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 39 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00009028002rxnav_ndcsyes
00009028003rxnav_ndcsyes
00009028051rxnav_ndcsyes
00009028052rxnav_ndcsyes
50090055600rxnav_ndcsyes
00009028024rxnav_historical
00009028025rxnav_historical
00009028032rxnav_historical_indirect
00009028033rxnav_historical_indirect
00009307301rxnav_historical
00009307302rxnav_historical_indirect
00009307303rxnav_historical
00009307322rxnav_historical
00009307323rxnav_historical
00247117105rxnav_historical
00247117110rxnav_historical
12280025601rxnav_historical_indirect
12280025605rxnav_historical_indirect
21695095201rxnav_historical
21695095205rxnav_historical
21695095210rxnav_historical
35356048310rxnav_historical
49349075501rxnav_historical
49349075508rxnav_historical
49349094801rxnav_historical
50090031201rxnav_historical
54569190101rxnav_historical
54569221300rxnav_historical
54569394600rxnav_historical
54569426500rxnav_historical
54771161401rxnav_historical
54868389600rxnav_historical
54868389601rxnav_historical
54868389602rxnav_historical
55045324202rxnav_historical
55045324205rxnav_historical
55154392905rxnav_historical
55154393005rxnav_historical_indirect
70518108800rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Depo-MedrolMETHYLPREDNISOLONE ACETATEPharmacia & Upjohn Company LLC823b0010-2b57-4e76-b5ac-4a8c2963438f2026-01-21Warnings, Adverse reactionsExact identifier
ndc (package): 0009-0280-51
ndc (package): 0009-0280-03
ndc (package): 0009-0280-02
ndc (package): 0009-0280-52
ndc (product): 0009-0280
ndc11 (package): 00009028051
ndc11 (package): 00009028052
ndc11 (package): 00009028003
ndc11 (package): 00009028002
rxcui: 1358612
Depo-MedrolMETHYLPREDNISOLONE ACETATEPharmacia & Upjohn Company LLC9a7b3837-e038-48bf-97e9-78ad463760dc2026-01-21Warnings, Adverse reactionsExact identifier
ndc11 (package): 00009307303
ndc11 (package): 00009307301
Depo-MedrolMETHYLPREDNISOLONE ACETATEPharmacia & Upjohn Company LLCbf1b104d-85cb-414d-a366-78068c82c8832025-12-01Warnings, Adverse reactionsExact identifier
ndc11 (package): 00009307323
ndc11 (package): 00009307322
DEPO-MEDROLMETHYLPREDNISOLONE ACETATEA-S Medication Solutionsaa151d12-bd33-4d26-848f-2195172c97002024-06-03Warnings, Adverse reactionsExact identifier
ndc (package): 50090-0556-0
ndc (product): 50090-0556
ndc11 (package): 50090055600
rxcui: 1358612

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
823b0010-2b57-4e76-b5ac-4a8c2963438fDepo-Medrol 40 MG/ML Injectable SuspensionSY22DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)20260121
823b0010-2b57-4e76-b5ac-4a8c2963438fmethylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol]SBD22DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)20260121
823b0010-2b57-4e76-b5ac-4a8c2963438fDEPO-Medrol 40 MG/ML Injectable SuspensionPSN22DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)20260121
aa151d12-bd33-4d26-848f-2195172c9700methylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol]SBD19DEPO-MEDROL20240603
aa151d12-bd33-4d26-848f-2195172c9700DEPO-Medrol 40 MG/ML Injectable SuspensionPSN19DEPO-MEDROL20240603
aa151d12-bd33-4d26-848f-2195172c9700Depo-Medrol 40 MG/ML Injectable SuspensionSY19DEPO-MEDROL20240603
f7d4269e-eb4c-46aa-805f-8e8662c80904DEPO-Medrol 40 MG/ML Injectable SuspensionPSN11DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)20210414
f7d4269e-eb4c-46aa-805f-8e8662c80904methylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol]SBD11DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)20210414
f7d4269e-eb4c-46aa-805f-8e8662c80904Depo-Medrol 40 MG/ML Injectable SuspensionSY11DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)20210414
9f1b7ce6-0733-47fa-8a14-a29a4d026992Depo-Medrol 40 MG/ML Injectable SuspensionSY6Depo-Medrol ®20260327
9f1b7ce6-0733-47fa-8a14-a29a4d026992DEPO-Medrol 40 MG/ML Injectable SuspensionPSN6Depo-Medrol ®20260327
9f1b7ce6-0733-47fa-8a14-a29a4d026992methylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol]SBD6Depo-Medrol ®20260327
41fa78f5-8f41-415e-80f3-7fee7091df5eDEPO-Medrol 40 MG/ML Injectable SuspensionPSN1DEPO-MEDROL ® methylprednisolone acetate injectable suspension, USP20110628
41fa78f5-8f41-415e-80f3-7fee7091df5emethylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol]SBD1DEPO-MEDROL ® methylprednisolone acetate injectable suspension, USP20110628
41fa78f5-8f41-415e-80f3-7fee7091df5eDepo-Medrol 40 MG/ML Injectable SuspensionSY1DEPO-MEDROL ® methylprednisolone acetate injectable suspension, USP20110628

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
9f1b7ce6-0733-47fa-8a14-a29a4d026992Depo-Medrol ®Zoetis Inc.20260327
9a7b3837-e038-48bf-97e9-78ad463760dcDEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A.20260121
823b0010-2b57-4e76-b5ac-4a8c2963438fDEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC20260121
bf1b104d-85cb-414d-a366-78068c82c883DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A.20251201
823b0010-2b57-4e76-b5ac-4a8c2963438fDEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC20251114
bf1b104d-85cb-414d-a366-78068c82c883DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A.20251008
9a7b3837-e038-48bf-97e9-78ad463760dcDEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A.20251006
bf1b104d-85cb-414d-a366-78068c82c883DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A.20250828
aa151d12-bd33-4d26-848f-2195172c9700DEPO-MEDROLA-S Medication Solutions20240603
754e9384-f4d4-70cf-e053-2a91aa0a9748Point Of Care Kit LM-DEP-2 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Bupivacaine HCI safely and effectively. See full prescribing information for Bupivacaine HCI. Bupivacaine HCI Injectables, USP Initial U.S. Approval:2013NuCare Pharmaceuticals,Inc.20210504
72dcd99f-59e3-a11f-e053-2a91aa0a4bd3DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)NuCare Pharmaceuticals,Inc.20210504
f7d4269e-eb4c-46aa-805f-8e8662c80904DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)A-S Medication Solutions20210414
9ba64a6c-fd63-4ae0-910b-9536e5021e00DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)REMEDYREPACK INC.20180410
92cb6339-75ab-48eb-b304-19db59695883DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Proficient Rx LP20140205
cb33bed8-6f99-4a00-aa3a-c74e4f0a17e7DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia and Upjohn Company LLC20140124
9adc594b-c5f8-43af-ae24-96cb0a8ea0feNational Council for Prescription Drug Programs20120724
14e42df1-6eeb-4d70-b05c-7f475b77f64eNational Council for Prescription Drug Programs20120724
a87c022e-a1a3-4fc7-83b5-545b9db82031National Council for Prescription Drug Programs20120724
73f87d3c-2cdf-451b-af46-1cdcf3694a87National Council for Prescription Drug Programs20120724
b0bc7e16-1801-42c2-a1f5-1dbaf8a8b6e5National Council for Prescription Drug Programs20120724
5d1907a1-afcc-42e8-b241-417e305065b0National Council for Prescription Drug Programs20120724
36d76072-beac-4b42-ba66-9f469d4d9ef9National Council for Prescription Drug Programs20120724
c7640deb-c893-461b-ad71-1f96ca6b6241National Council for Prescription Drug Programs20120724
d042f2d5-908d-4e80-9c5e-2e4fc590d833National Council for Prescription Drug Programs20120724
e8e71950-b4ff-4bb1-95c2-34961ce56314National Council for Prescription Drug Programs20120724
f2c67ef7-89c4-454b-bf7c-539fb4856011National Council for Prescription Drug Programs20120724
292a8e6c-a5a0-4ffc-ad29-22641e1484d6National Council for Prescription Drug Programs20120724
41fa78f5-8f41-415e-80f3-7fee7091df5eDEPO-MEDROL ® methylprednisolone acetate injectable suspension, USPRebel Distributors Corp20110628

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD10AACorticosteroids, combinations for treatment of acneATC1-4methylprednisolone
ATCD07AACorticosteroids, weak (group I)ATC1-4methylprednisolone
ATCH02ABGlucocorticoidsATC1-4methylprednisolone
FDASPLN0000175576CorticosteroidEPChas_epcmethylprednisolone
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moamethylprednisolone
MEDRTD008775MethylprednisoloneCHEMhas_ingredientmethylprednisolone
MEDRTD000077555Methylprednisolone AcetateCHEMhas_ingredientmethylprednisolone acetate
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treatmethylprednisolone acetate
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treatmethylprednisolone
MEDRTD015210Arthritis, GoutyDISEASEmay_preventmethylprednisolone acetate
MEDRTD015210Arthritis, GoutyDISEASEmay_preventmethylprednisolone
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventmethylprednisolone
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventmethylprednisolone acetate
MEDRTD001249AsthmaDISEASEmay_treatmethylprednisolone
MEDRTD001249AsthmaDISEASEmay_treatmethylprednisolone acetate
MEDRTD001607BerylliosisDISEASEmay_treatmethylprednisolone acetate
MEDRTD001607BerylliosisDISEASEmay_treatmethylprednisolone
MEDRTD001932Brain NeoplasmsDISEASEmay_treatmethylprednisolone acetate
MEDRTD001932Brain NeoplasmsDISEASEmay_treatmethylprednisolone
MEDRTD003093Colitis, UlcerativeDISEASEmay_treatmethylprednisolone acetate
MEDRTD003093Colitis, UlcerativeDISEASEmay_treatmethylprednisolone
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treatmethylprednisolone acetate
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treatmethylprednisolone
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatmethylprednisolone acetate
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatmethylprednisolone
MEDRTD004342Drug HypersensitivityDISEASEci_withmethylprednisolone acetate
MEDRTD004342Drug HypersensitivityDISEASEci_withmethylprednisolone
MEDRTD004892Erythema MultiformeDISEASEmay_treatmethylprednisolone acetate
MEDRTD004892Erythema MultiformeDISEASEmay_treatmethylprednisolone
MEDRTD006086Graft vs Host DiseaseDISEASEmay_preventmethylprednisolone
MEDRTD006086Graft vs Host DiseaseDISEASEmay_treatmethylprednisolone
MEDRTD006086Graft vs Host DiseaseDISEASEmay_treatmethylprednisolone acetate
MEDRTD006086Graft vs Host DiseaseDISEASEmay_preventmethylprednisolone acetate
MEDRTD006402Hematologic DiseasesDISEASEmay_treatmethylprednisolone
MEDRTD006402Hematologic DiseasesDISEASEmay_treatmethylprednisolone acetate
MEDRTD006934HypercalcemiaDISEASEmay_treatmethylprednisolone
MEDRTD006934HypercalcemiaDISEASEmay_treatmethylprednisolone acetate
MEDRTD007223InfantDISEASEci_withmethylprednisolone
MEDRTD007223InfantDISEASEci_withmethylprednisolone acetate
MEDRTD007249InflammationDISEASEmay_treatmethylprednisolone
MEDRTD007249InflammationDISEASEmay_treatmethylprednisolone acetate
MEDRTD007938LeukemiaDISEASEmay_treatmethylprednisolone
MEDRTD007938LeukemiaDISEASEmay_treatmethylprednisolone acetate
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treatmethylprednisolone acetate
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treatmethylprednisolone
MEDRTD009103Multiple SclerosisDISEASEmay_treatmethylprednisolone acetate
MEDRTD009103Multiple SclerosisDISEASEmay_treatmethylprednisolone
MEDRTD009181MycosesDISEASEci_withmethylprednisolone acetate
MEDRTD009181MycosesDISEASEci_withmethylprednisolone
MEDRTD009182Mycosis FungoidesDISEASEmay_treatmethylprednisolone
MEDRTD009182Mycosis FungoidesDISEASEmay_treatmethylprednisolone acetate
MEDRTD009404Nephrotic SyndromeDISEASEmay_treatmethylprednisolone
MEDRTD009404Nephrotic SyndromeDISEASEmay_treatmethylprednisolone acetate
MEDRTD009461Neurologic ManifestationsDISEASEmay_treatmethylprednisolone
MEDRTD009461Neurologic ManifestationsDISEASEmay_treatmethylprednisolone acetate
MEDRTD010392PemphigusDISEASEmay_treatmethylprednisolone
MEDRTD010392PemphigusDISEASEmay_treatmethylprednisolone acetate
MEDRTD012128Respiratory Distress SyndromeDISEASEmay_treatmethylprednisolone
MEDRTD012128Respiratory Distress SyndromeDISEASEmay_treatmethylprednisolone acetate
MEDRTD012216Rheumatic DiseasesDISEASEmay_treatmethylprednisolone
MEDRTD012216Rheumatic DiseasesDISEASEmay_treatmethylprednisolone acetate
MEDRTD012507SarcoidosisDISEASEmay_treatmethylprednisolone
MEDRTD012507SarcoidosisDISEASEmay_treatmethylprednisolone acetate
MEDRTD012713Serum SicknessDISEASEmay_treatmethylprednisolone acetate
MEDRTD012713Serum SicknessDISEASEmay_treatmethylprednisolone
MEDRTD012874Skin Diseases, InfectiousDISEASEci_withmethylprednisolone
MEDRTD012874Skin Diseases, InfectiousDISEASEci_withmethylprednisolone acetate
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treatmethylprednisolone acetate
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treatmethylprednisolone
MEDRTD013585SynovitisDISEASEmay_treatmethylprednisolone
MEDRTD013585SynovitisDISEASEmay_treatmethylprednisolone acetate
MEDRTD013966ThyroiditisDISEASEmay_treatmethylprednisolone acetate
MEDRTD013966ThyroiditisDISEASEmay_treatmethylprednisolone
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treatmethylprednisolone
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treatmethylprednisolone acetate
MEDRTD014605UveitisDISEASEmay_treatmethylprednisolone acetate
MEDRTD014605UveitisDISEASEmay_treatmethylprednisolone
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moamethylprednisolone
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moamethylprednisolone acetate
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moamethylprednisolone acetate
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moamethylprednisolone
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_pemethylprednisolone
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_pemethylprednisolone acetate
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_pemethylprednisolone acetate
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_pemethylprednisolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_pemethylprednisolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_pemethylprednisolone acetate
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_pemethylprednisolone acetate
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_pemethylprednisolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pemethylprednisolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pemethylprednisolone acetate
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_pemethylprednisolone acetate
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_pemethylprednisolone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pemethylprednisolone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pemethylprednisolone acetate
MEDRTN0000008841Decreased Protein SynthesisPEhas_pemethylprednisolone acetate
MEDRTN0000008841Decreased Protein SynthesisPEhas_pemethylprednisolone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pemethylprednisolone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pemethylprednisolone acetate
MEDRTN0000009739Lipid Metabolism AlterationPEhas_pemethylprednisolone acetate
MEDRTN0000009739Lipid Metabolism AlterationPEhas_pemethylprednisolone
MEDRTN0000009741Lysosomal Function AlterationPEhas_pemethylprednisolone
MEDRTN0000009741Lysosomal Function AlterationPEhas_pemethylprednisolone acetate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH40 MG/ML (expressed as methylprednisolone acetate)
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESRXNAV_VET_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSBD
ATTRIBUTESVET_DRUGUS
CODESMMSL_CODEMTH_RXN_BD2312
CODESNADANADA012204
CODESNDANDA011757
CODESRxCUI1358612
CODESSPL_SET_ID823b0010-2b57-4e76-b5ac-4a8c2963438f
CODESSPL_SET_ID9f1b7ce6-0733-47fa-8a14-a29a4d026992
CODESSPL_SET_IDaa151d12-bd33-4d26-848f-2195172c9700
NAMESPrescribable SynonymDEPO-Medrol 40 MG/ML Injectable Suspension
NAMESRXNAV_STRDEPO-Medrol 40 MG/ML Injectable Suspension
NAMESRxNorm Namemethylprednisolone acetate 40 MG/ML Injectable Suspension [Depo-Medrol]
NAMESRxNorm SynonymDepo-Medrol 40 MG/ML Injectable Suspension
NAMESTallman SynonymDEPO-Medrol 40 MG/ML Injectable Suspension
NAMESTallman SynonymmethylPREDNISolone acetate 40 MG/ML Injectable Suspension [DEPO-Medrol]
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon